Circe Biomedical Overview

  • Year Founded
  • 1996

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 25

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $26M

Circe Biomedical General Information

Description

Developer of bioartificial organs from isolated mammalian cells and membranes for patients suffering from acute, end-stage liver failure. The company's product HepatAssist® Liver Support System integrates viable liver cells with biocompatible membranes into an extracorporeal, bioartificial liver assist system.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 99 Hayden Avenue
  • Lexington, MA 02421
  • United States
+1 (781)
Primary Industry
Therapeutic Devices
Other Industries
Biotechnology
Corporate Office
  • 99 Hayden Avenue
  • Lexington, MA 02421
  • United States
+1 (781)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Circe Biomedical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 11-Mar-2002 $26M Completed Product Development
2. Later Stage VC (Series C) 18-Dec-2000 Completed Product Development
1. Early Stage VC 07-Apr-1999 $16.4M $16.4M Completed Product Development
To view Circe Biomedical’s complete valuation and funding history, request access »

Circe Biomedical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C
Series B
Series A 799,920 $0.010000 $0.5 $0.5 1x $0.5 1.6%
To view Circe Biomedical’s complete cap table history, request access »

Circe Biomedical Patents

Circe Biomedical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2382109-A1 Astrocyte apparatus for bioprocessing a circulating fluid Inactive 23-Aug-1999
EP-1220889-A1 Astrocyte apparatus for bioprocessing a circulating fluid Inactive 23-Aug-1999
WO-2001014516-A1 Astrocyte apparatus for bioprocessing a circulating fluid Inactive 23-Aug-1999
US-6136593-A Device for the removal of toxins from blood Inactive 23-Aug-1999
US-6300054-B1 Removing toxins from biological fluids by treating the fluid with astocytes in vitro; therapy for liver failure Inactive 23-Aug-1999 A61M1/3472
To view Circe Biomedical’s complete patent history, request access »

Circe Biomedical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Circe Biomedical Former Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Advanced Technology Ventures Venture Capital Minority
Asahi Chemical Corporation Minority
BancBoston Ventures Venture Capital Minority
Bessemer Venture Partners Venture Capital Minority
Burrill & Co Merchant Banking Firm Minority
You’re viewing 5 of 10 investors. Get the full list »

Circe Biomedical FAQs

  • When was Circe Biomedical founded?

    Circe Biomedical was founded in 1996.

  • Where is Circe Biomedical headquartered?

    Circe Biomedical is headquartered in Lexington, MA.

  • What is the size of Circe Biomedical?

    Circe Biomedical has 25 total employees.

  • What industry is Circe Biomedical in?

    Circe Biomedical’s primary industry is Therapeutic Devices.

  • Is Circe Biomedical a private or public company?

    Circe Biomedical is a Private company.

  • What is the current valuation of Circe Biomedical?

    The current valuation of Circe Biomedical is .

  • What is Circe Biomedical’s current revenue?

    The current revenue for Circe Biomedical is .

  • How much funding has Circe Biomedical raised over time?

    Circe Biomedical has raised $44.4M.

  • Who are Circe Biomedical’s investors?

    Advanced Technology Ventures, Asahi Chemical, BancBoston Ventures, Bessemer Venture Partners, and Burrill & Co are 5 of 10 investors who have invested in Circe Biomedical.

  • When was Circe Biomedical acquired?

    Circe Biomedical was acquired on 11-Mar-2002.

  • Who acquired Circe Biomedical?

    Circe Biomedical was acquired by Bausch Health Companies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process